v3.25.2
Reverse Recapitalization (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2025
Feb. 28, 2025
Feb. 11, 2025
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2024
Reverse Recapitalization [Line Items]                  
Share converted (in Shares)           501,140      
Common stock exchange ratio           The shares and net loss per share, prior to the Merger, have been retroactively restated to reflect the common stock exchange ratio of 2,159.47-for-1, as established in the Merger.      
Reclassified additional paid-in capital           $ 279,746    
Aggregate purchase price of private placement           $ 6,161,505    
Number of warrant (in Shares)       2,583,169   2,583,169      
Exercise price (in Dollars per share)       $ 4.96   $ 4.96      
Total cash commission           10.00%      
Non-allocable expense allowance           2.00%      
Percentage of common stock equal to warrant           10.00%      
Common stock, share issued (in Shares) [1]       8,455,829   8,455,829     3,249,999
Warrant to purchase shares (in Shares)       132,570   132,570      
Equity issuance costs           $ 1,266,485    
Conversion price (in Dollars per share)           $ 3.3      
Common stock at an exercise price (in Dollars per share)           3.3      
Common stock at an exercise price (in Dollars per share)           $ 4.4      
Debt issuance costs       $ 197,570   $ 197,570      
Derivative liabilities       551,269   551,269      
Reacquisition price           1,681,165      
Fair value of warrants           6,312 2,506    
Gain on extinguishment       326,345    
Private Adaptin’s Exchange Notes [Member]                  
Reverse Recapitalization [Line Items]                  
Principal amount           $ 1,500,000      
Secured Promissory Notes [Member]                  
Reverse Recapitalization [Line Items]                  
Secured promissory notes issued               10.00%  
2024 Convertible Debt [Member]                  
Reverse Recapitalization [Line Items]                  
Secured promissory notes issued           10.00%      
Conversion of Exchange Notes and 2024 Notes [Member]                  
Reverse Recapitalization [Line Items]                  
Debt amount       2,007,510   $ 2,007,510      
Principal amount       $ 1,500,000   1,500,000      
Accrued interest           $ 153,811      
A Warrant [Member]                  
Reverse Recapitalization [Line Items]                  
Number of warrant (in Shares)     1            
Exercise price (in Dollars per share)     $ 4.4            
Warrant term     1 year            
B Warrant [Member]                  
Reverse Recapitalization [Line Items]                  
Number of warrant (in Shares)     0.5            
Exercise price (in Dollars per share)     $ 6.6            
Warrant term     5 years            
Placement Agent Warrants [Member]                  
Reverse Recapitalization [Line Items]                  
Exercise price (in Dollars per share)       $ 4.4   $ 4.4      
Warrant term       7 years   7 years      
Warrant [Member]                  
Reverse Recapitalization [Line Items]                  
Fair value of warrants           $ 247,906      
Unite Acquisition 1 Corp. [Member]                  
Reverse Recapitalization [Line Items]                  
Share converted (in Shares)     3,249,999            
Lucius Partners LLC [Member]                  
Reverse Recapitalization [Line Items]                  
Common stock retained (in Shares)     3,250,000            
Share cancel and retire (in Shares)     1,750,000            
Private Placement [Member]                  
Reverse Recapitalization [Line Items]                  
Private placement offering issued (in Shares)     1,080,814            
Aggregate purchase price of private placement     $ 4,755,582            
Per share price (in Dollars per share)     $ 4.4            
Maximum Offering [Member]                  
Reverse Recapitalization [Line Items]                  
Private placement offering issued (in Shares) 319,528                
Maximum offering amount sold   $ 8,500,000              
Aggregate purchase price $ 1,405,923                
Common Stock [Member]                  
Reverse Recapitalization [Line Items]                  
Number of shares in a unit (in Shares)     1            
Common stock, share issued (in Shares)       1,400,342   1,400,342      
Gross proceeds           $ 6,161,505      
Equity issuance costs           1,460,361      
Net proceeds           4,701,144      
Fair value of warrants           $ 1,433,259      
Common Stock [Member] | Placement Agent Warrants [Member]                  
Reverse Recapitalization [Line Items]                  
Warrant to purchase shares (in Shares)       350,086   350,086      
Common Stock [Member] | Warrant [Member]                  
Reverse Recapitalization [Line Items]                  
Warrant to purchase shares (in Shares)       2,100,513   2,100,513      
[1] The number of shares and per share value of the Company’s common stock have been retroactively recast to reflect the exchange ratio pursuant to the Merger.